Abstract
Introduction
Despite unique tumor epidemiology and a higher cancer incidence compared to pediatric patients, adolescents and young adults have not been receiving specialized, multidisciplinary, centralized care. In an effort to emphasize this need, we present outcome and toxicity data from a reference centre.
Methods
Cohort of 150 patients aged 15–30 treated for malignant tumors of lymphoid and solid organs from 1986 to 2002.
Results
Patients aged 15–19 commonly had lymphomas, germ cell tumors and pediatric sarcomas, whereas those aged 20–30 experienced germ cell tumors, lymphomas, melanomas and epithelial tumors more often. Overall 5- and 10-year survival was 80%, whereas 5-year and 10-year time to treatment failure was 68% and 43.5% respectively. 24% of patients experienced persistent, late treatment-related toxicities that interfered with their normal lifestyle.
Conclusion
Despite the need for specialized care, psychosocial support and enrollment in clinical trials, youngsters have not been recognized as a patient group with distinct needs. Development of «Juvenile» oncology is required.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Coleman MP, Babb P, Damiecki P, et al. Cancer survival trends in England and Wales 1971–1995: deprivation and NHS region. London 1999, HMSO.
Bleyer WA. Cancer in older adolescents and young adults: epidemiology, diagnosis, treatment, survival and importance of clinical trials. Med Pediatr Oncol. 2002;38:1–10.
Ries LAG, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973–1997. Bethesda, MD: National Cancer Institute, 2000.
Parkin DM, Kramarova E, Draper GJ, et al. International incidence of childhood cancer. Vol II, IARC Scientific Publication no 144. International Agency for Research on Cancer, 1998; Lyons, France.
Smith MA, Gurney JG, Ries LAG. Cancer in adolescents 15–19 years old. In: Ries LAG, Smith MA, Gurney JG, et al, editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1997, National Cancer Institute SEER Program, Bethesda MD, 1999; NIH Pub no 99-4649.
Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ. Classification and incidence of cancer in adolescents and adults in England 1979–1997. Br J Cancer. 2002;87:1267–74.
Reaman G, Bonfiglio J, Krailo A, et al. Cancer in adolescents and young adults. Cancer. 1993;71 (10 Suppl):S3206–9.
Fritschi L, Coates M, McCredie M. Incidence of cancer among New South Wales adolescents: Which classification scheme describes adolescent cancers better? Int J Cancer. 1995;60:555–60.
Lewis IJ. Cancer in adolescence. Br Med Bull. 1996;52:887–97.
Bleyer WA, Tejeda H, Murphy SM. National cancer clinical trials: Children have equal success;a dolescents do not. J Adolesc Health. 1997;21:366–73.
Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents (15–20 years) with ALL be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol. 2003;2(5):774–80.
Bleyer WA. The adolescent gap in cancer treatment. J Regist Manage. 1996;23:114–5.
Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71 (10 Suppl):S3441–9.
Selby P, Bailey C, editors. Cancer and the adolescent. London: BMJ Publishing Group; 1996.
Nichols MI. Social support and coping in young adolescents with cancer. Pediatr Nurs. 1995;21:235–40.
Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med. 1996;125:47–58.
Jones JM, Ribeiro GG. Mortality patterns over 34 years of breast cancer patients in a clinical trial of post-operative radiotherapy. Clin Radiol. 1989;40:204.
Viviani S, Sandoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP versus ABVD. Eur J Cancer. 1985;21:601.
Mulhern RK, Tyc VL, Phipps S, et al. Health-related behaviours of survivors of childhood cancer. Med Pediatr Oncol. 1995; 25:159–65.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pentheroudakis, G., Mauri, D., Kostadima, L. et al. «Juvenile» oncology - a missing subspecialty. The experience of a reference cancer centre. Clin Transl Oncol 8, 444–449 (2006). https://doi.org/10.1007/s12094-006-0199-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0199-1